Comparison of Allogeneic Stem Cell Transplantation and Best Supportive Care in Elderly Patients with Advanced MDS

被引：0
|
作者：
Kroger, Nicolaus [1 ]
Putter, Hein [2 ]
Brand, Ronald [3 ]
Kuendgen, Andrea [4 ]
de Witte, T. M. [5 ]
Germing, Ulrich [6 ]
机构：
[1] Univ Med Ctr, Hamburg, Germany
[2] Univ Med Ctr, Dept Stat, Leiden, Netherlands
[3] Leiden Univ, Med Ctr, Dept Med Stat & Bioinformat, Leiden, Netherlands
[4] Univ Hosp, Dusseldorf, Germany
[5] Radboud Univ Nijmegen, Med Ctr, NL-6525 ED Nijmegen, Netherlands
[6] Univ Klin Dusseldorf, Dusseldorf, Germany
来源：
BLOOD | 2009年 / 114卷 / 22期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1305 / 1306
页数：2
相关论文
共 50 条
  • [21] RELAPSE AFTER ALLOGENEIC STEM CELL TRANSPLANTATION (SCT): RETRANSPLANTATION DOES NOT IMPROVE OUTCOME IN COMPARISON TO SUPPORTIVE CARE AND CHEMOTHERAPY
    Arnold, R.
    Hemmati, P.
    Terwey, T.
    Voung, L.
    le Coutre, P.
    Doerken, B.
    Massenkeil, G.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2011, 17 (02) : S315 - S315
  • [22] Allogeneic hematopoietic stem cell transplantation in elderly
    Castagna, Luca
    Blaise, Didier
    Furst, Sabine
    BULLETIN DU CANCER, 2011, 98 (08) : 915 - 925
  • [23] Allogeneic hematopoietic stem cell transplantation in the elderly
    Shapira, Michael Y.
    Tsirigotis, P.
    Resnick, I. B.
    Or, R.
    Abdul-Hai, A.
    Slavin, S.
    CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2007, 64 (01) : 49 - 63
  • [24] ALLOGENEIC STEM CELL TRANSPLANTATION FOR MDS WITH BONE MARROW FIBROSIS
    Kroger, N.
    Zabelina, T.
    van Biezen, A.
    Brand, R.
    de Witte, T.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2010, 95 : 127 - 127
  • [25] Randomized comparison between chemotherapy plus best supportive care with best supportive care in advanced gastric cancer
    Glimelius, B
    Ekstrom, K
    Hoffman, K
    Graf, W
    Sjoden, PO
    Haglund, U
    Svensson, C
    Enander, LK
    Linne, T
    Sellstrom, H
    Heuman, R
    ANNALS OF ONCOLOGY, 1997, 8 (02) : 163 - 168
  • [26] Use of azacytidine as a bridge to allogeneic stem cell transplantation in MDS
    Pol, R. R.
    Raj, K.
    Lazana, I.
    Russell, N.
    Ferguson, P.
    Craddock, C.
    Mehta, P.
    Killick, S.
    Das-Gupta, E.
    BONE MARROW TRANSPLANTATION, 2015, 50 : S305 - S305
  • [27] Unrelated cord blood allogeneic stem cell transplantation for MDS
    Laughlin, MJ
    LEUKEMIA & LYMPHOMA, 2006, 47 (04) : 569 - 570
  • [28] Allogeneic peripheral blood stem cell transplantation in patients with advanced hematologic malignancies: A retrospective comparison with marrow transplantation
    Bensinger, WI
    Clift, R
    Martin, P
    Appelbaum, FR
    Demirer, T
    Gooley, T
    Lilleby, K
    Rowley, S
    Sanders, J
    Storb, R
    Buckner, CD
    BLOOD, 1996, 88 (07) : 2794 - 2800
  • [29] Allogeneic stem cell transplantation results in our myelodysplastic syndrome (MDS) patients.
    Gurman, Gunhan
    Ataca, Pinar
    Aydin, Tolga
    Atilla, Erden
    Bozdag, Sinem Civriz
    Toprak, Selami Kocak
    Yuksel, Meltem Kurt
    Topcuoglu, Pervin
    Ozcan, Muhit
    Demirer, Taner
    Beksac, Meral
    Ilhan, Osman
    Akan, Hamdi
    Konuk, Nahide
    Arslan, Onder
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
  • [30] Supportive Care Only Versus Allogeneic Hematopoietic Cell Transplantation in Patients ≥ 60 Years with De Novo High-Risk MDS
    Platzbecker, Uwe
    Finke, Juergen
    Trenschel, Rudolf
    Kerstin, Schaefer-Eckart
    Bornhauser, Martin
    Kobbe, Guido
    Scott, Bart L.
    Ehninger, Gerhard
    Beelen, Dietrich
    Deeg, H. J.
    Germing, Ulrich
    BLOOD, 2009, 114 (22) : 247 - 247
12345